🇺🇸 Hepatitis A Virus in United States
59 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 59
Most-reported reactions
- Drug Intolerance — 8 reports (13.56%)
- Pain — 8 reports (13.56%)
- Arthralgia — 6 reports (10.17%)
- Cough — 6 reports (10.17%)
- Febrile Neutropenia — 6 reports (10.17%)
- Gastrointestinal Disorder — 6 reports (10.17%)
- Cellulitis — 5 reports (8.47%)
- Drug Hypersensitivity — 5 reports (8.47%)
- Muscle Spasms — 5 reports (8.47%)
- Anxiety — 4 reports (6.78%)
Other Immunology / Infectious Disease approved in United States
Frequently asked questions
Is Hepatitis A Virus approved in United States?
Hepatitis A Virus does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Hepatitis A Virus in United States?
Novartis is the originator. The local marketing authorisation holder may differ — check the official source linked above.